SPRY icon

ARS Pharmaceuticals
SPRY

Overview Fund Trends Analyst Outlook Journalist POV

62 hedge funds and large institutions have $1.13B invested in ARS Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
62
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$405M
2
+$156M
3
+$117M
4
RCM
RA Capital Management
Massachusetts
+$80.7M
5
BC
Boxer Capital
California
+$77.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$386K
52
$232K
53
$232K
54
$232K
55
$205K
56
$110K
57
$46K
58
$12K
59
$8K
60
$4K
61
$1.16K
62
$1K
1 2
3